Author: Patlee

This is a test

Overcoming hurdles developing neuroprotective drugs

Title: Overcoming hurdles developing neuroprotective drugs

Author: Marcel Alavi, Founder of 712 North

Date: 02/27/2018

Brief Description:
712 North is a biopharma developing medical interventions for patients with Alzheimer’s and other forms of dementia. Medicines currently available for this devastating disease only treat the cognitive symptoms, but do not affect the underlying causes of the disorder. We identified a novel mechanism-of-action that can complement all existing efforts to treat Alzheimer’s by studying a rare eye disease called Autosomal Dominant Optic Atrophy. We strongly believe, and as a matter of fact we have the data to support this claim, that whatever helps patients with ADOA will help patients with Alzheimer’s disease as well.

Attachment:

To see this content, please login

SenSonic – The World Debut of the “Neckband Style” Self-Programmable, Wireless Hearing Aid

Title: SenSonic – The World Debut of the “Neckband Style” Self-Programmable, Wireless Hearing Aid

Speaker: Asela Udhaya Bandara Jayampathy, Co-Founder and CEO BioSound

Date: 02/13/2018

Brief Description:
SenSonic is the world’s only hearing aid capable of user-configurable audiometric measurement and shift-on-the-fly reprogramming when the wearer moves from one environment to another. This is a revolutionary step towards empowering wearers with self-programmable hearing aids that do not require the intervention of an audiologist.
1) SenSonic Neckband Hearing Aid has the widest distance between Microphones and Receivers eliminating the need to have an
acoustic feedback cancellation algorithm which compromises speech amplification.
2) Wireless Ear Sets with Interchangeable Receivers tuned to hear speech or hi-resolution music.

Attachment:

To see this content, please login

Rising Obesity in America, with the primary focus on childhood obesity.

Title: Rising Obesity in America, with the primary focus on childhood obesity.

Speaker: Anamika Sharma, MD

Date:  01/30/2018

Brief Description:
Rising problem of obesity in America with primary focus on childhood obesity. Dr. Sharma talked about prevention and different options of medical treatment with discussion of few FDA approved medicines and patients screening, assessment for surgical treatments.

Attachment:

To see this content, please login

The Promise and Peril of Agile for Medical Devices

Title: The Promise and Peril of Agile for Medical Devices

Speaker: Aaron Joseph

Date: 01/23/2018

Brief Description:
Agile methods promise faster development of medical devices but at the peril of jeopardizing regulatory compliance. Learn about four key rules to follow to ensure you don’t sacrifice compliance in order to take advantage of agile methods. Aaron covered how
agile methods can lower risks, improve quality, & shorten time to market for medical device development. He also covered basic principles behind agile & lean methods & important adaptations needed for the particular needs of medical device companies.

Attachment:

To see this content, please login

From Condoms to Brain Implants: Protecting Patient Safety Across the Device Spectrum Through Biological Assessment

Title: From Condoms to Brain Implants: Protecting Patient Safety Across the Device Spectrum Through Biological Assessment

Speakers: Thor Rollins, Audrey Turley

Date: 12/05/2017

Brief Description:
Using a risk-based approach to address biocompatibility has become mainstream, and actively encouraged by the FDA. This strategy allows manufacturers to leverage previous testing knowledge of device materials and chemistry to reduce their testing burden while improving patient safety. The caveat? Manufacturers have to better understand their materials and how they interact with the body.

Attachment:

To see this content, please login

Sprout Medical, Making an Impact in Critical Care

Title: Sprout Medical, Making an Impact in Critical Care

Speaker: Jerry Gibson, CEO, Sprout Medical

Date: 11/14/2017

Brief Description:
Sprout Medical has developed a cost-effective system to increase the clinical efficiency of administrating the rapid infusion of
various fluids that are so important in the treatment of sepsis, trauma and other critical conditions in the ED, ICU, OR and prehospital
environments. Mr. Gibson will review the clinical and competitive landscape as well as Sprout Medical’s approach to
tackling this important issue.

Attachment:

To see this content, please login

Disrupting the Standard of Care Through the Novel Combination of Wearable Devices and Data Analytics

Title: Disrupting the Standard of Care Through the Novel Combination of Wearable Devices and Data Analytics

Speaker: Justin Cambra, Senior Director of Systems Development, iRhythm

Date: 10/24/2017

Brief Description:
Justin Cambra’s talk will review how iRhythm Technologies is disrupting the standard of care in diagnosing cardiac arrhythmias through the Zio Patch, Machine-Learned Algorithms, and data analysis. It will cover successes, challenges, and lessons learned utilizing data to grow and scale the diagnostic service.

Attachment:

To see this content, please login

Building Wearables to Detect Patient Deterioration Earlier

Title: Building Wearables to Detect Patient Deterioration Earlier

Speaker: Werner Vorster, Founder & CEO

Date: 10/17/2017

Brief Description:
Our journey from founding a hardware company (with backgrounds in business, software engineering and accounting…) to building wearables that will change the inpatient and outpatient experience for Physicians, Nurses and Patients. Ultimately a multi-sensor ability to follow the condition of pediatric and adult patients.

Attachment:

To see this content, please login

The Next Generation In-Vivo Discovery Platform; using technology to advance and accelerate drug development.

Title: The Next Generation In-Vivo Discovery Platform; using technology to advance and accelerate drug development.

Speakers: Larry Stevens and Abe Couse, Vium

Date: 10/10/2017

Brief Description:
Vium is a Silicon Valley start-up applying hardware, and software technology aimed at improving the efficiency of drug development. The company’s focus is on in vivo drug testing, a key step within the preclinical drug development pipeline where processes and methodologies have been largely unchanged for 30 years. Vium is developing a fully integrated platform including hardware, software, computer vision and data analytics backed by a cloud infrastructure. We will share the story of Vium’s technology and opportunities driven by our client’s needs.

Attachment:

To see this content, please login

Operationalizing Product Management for Telehealth Devices

Title: Operationalizing Product Management for Telehealth Devices

Speaker:  Padmasri Bhetanabhotla, Director of Product Management, HealthExpense, Inc.

Date: 10/03/2017

Brief Description:
The talk covered how to operationalize product development for a medical device. Real life examples were presented from her experience as a Product Manager leading teams that were developing new products or making revisions to existing products. Padmasri discussed the challenges she faced and how she optimized new and existing products through the process. Finally, she will review lessons learned to help prevent from encountering some of the challenges we faced.

Attachment:

To see this content, please login